CAMK2G and myocardial infarction: Cardiac-specific PRMT1 ablation induces myocardium hypertrophy and heart attack through CaMKII dysregulation (33), while skeletal muscle–specific Prmt1 KO leads to muscle atrophy via hyperactivated FOXO3 with enhanced energy deprivation (27).